"Proteomics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The systematic study of the complete complement of proteins (PROTEOME) of organisms.
| Descriptor ID |
D040901
|
| MeSH Number(s) |
H01.158.201.843 H01.158.273.180.350.700 H01.158.273.343.350.700 H01.181.122.738
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proteomics".
Below are MeSH descriptors whose meaning is more specific than "Proteomics".
This graph shows the total number of publications written about "Proteomics" by people in this website by year, and whether "Proteomics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 3 | 4 |
| 2005 | 2 | 3 | 5 |
| 2006 | 9 | 4 | 13 |
| 2007 | 3 | 1 | 4 |
| 2008 | 6 | 2 | 8 |
| 2009 | 6 | 7 | 13 |
| 2010 | 8 | 5 | 13 |
| 2011 | 10 | 6 | 16 |
| 2012 | 7 | 11 | 18 |
| 2013 | 5 | 5 | 10 |
| 2014 | 4 | 9 | 13 |
| 2015 | 9 | 6 | 15 |
| 2016 | 16 | 10 | 26 |
| 2017 | 10 | 12 | 22 |
| 2018 | 6 | 10 | 16 |
| 2019 | 8 | 18 | 26 |
| 2020 | 10 | 13 | 23 |
| 2021 | 11 | 21 | 32 |
| 2022 | 9 | 28 | 37 |
| 2023 | 12 | 22 | 34 |
| 2024 | 13 | 17 | 30 |
| 2025 | 20 | 15 | 35 |
| 2026 | 7 | 10 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proteomics" by people in Profiles.
-
Multimodal Noninvasive Biomarker Characterization of Structural and Functional Alterations in ADSS1-Deficient Myopathy. J Inherit Metab Dis. 2026 May; 49(3):e70193.
-
NANOG Proximity Proteomics Maps Neighborhood Hubs Linked to Mesenchymal Stem Cell Stemness and Chromatin Control. Biomolecules. 2026 Apr 02; 16(4).
-
Plasma Proteins Associated With Psychosocial Factors and Heart Disease: The Jackson Heart Study. Arterioscler Thromb Vasc Biol. 2026 May; 46(5):e324125.
-
Integration of cross-species multi-omics with in vivo experimental validation identifies Parkinson's disease therapeutic targets and novel risk factors within endolysosomal pathway subnetworks. Neurobiol Dis. 2026 05; 222:107364.
-
Proteomics Analysis of Plasma for Risk of Sepsis: Findings from the Atherosclerosis Risk in Communities Study. J Appl Lab Med. 2026 Mar 05; 11(2):281-294.
-
Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood Adv. 2026 Feb 24; 10(4):960-972.
-
Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood Adv. 2026 Feb 24; 10(4):960-972.
-
New approaches to uncover COPD pathobiology and develop therapies. JCI Insight. 2026 Feb 23; 11(4).
-
Proteomic Profiling of Pulmonary Function and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2026 Mar 03; 15(5):e043281.
-
Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism. Circulation. 2026 Mar 17; 153(11):810-825.